chrisvoncsefalvay/vaers-outcomes huggingface dataset:
tested positive for the Covid virus after the first vaccine; tested positive for the Covid virus after the first vaccine; This is a spontaneous report from a contactable consumer (patient) via a Pfizer-sponsored program. A female patient of an unspecified age received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 1st dose, single for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was hospitalized, when she tested positive for the Covid virus after the first vaccine on an unspecified date. She stated she would have been getting her second dose on 05May2021. She was not in the hospital anymore at the time of report, but still can't go outside. Outcome of the events was unknown.  Information on Lot/Batch number has been requested.; Sender's Comments: Linked Report(s) : PFIZER INC-2021507654 similar report from same reporter
Tinnitus; This is a spontaneous report from a contactable physician. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 13Apr2021 (Lot Number: ER8730) as 1ST DOSE, SINGLE for covid-19 immunisation.  Medical history was reported as none.  There were no concomitant medications.  The patient experienced tinnitus on 14Apr2021.  Reporter seriousness for Tinnitus: Not serious, but these symptoms could go on to be very troublesome long term. Treatment: Cortisone Treatment, saw ENT, Lipoflavanoids. Causation: Caller stated he read the tinnitus could be one of the symptoms related to viral syndromes. Caller stated he understands the vaccine does not contain viruses and it could be occurring simultaneously with another viral syndrome. States he can only speak on the information she gave him today in the letter. Reporter stated this was the patient's first dose, she refused the second dose. The event Tinnitus required a visit to Physician Office. The outcome of the event was recovering.   No follow-up attempts are needed. No further information is expected
Severe chest pain & pressure/nausea/vomiting/body aches/headache.
Information has been received from a pharmacist concerning a 76 year old patient who on an unspecified date was vaccinated with PREVNAR instead of PNEUMOVAX by mistake. The pharmacist stated that "this was not a product confusion". Another pharmacist reported that the PNEUMOVAX that the patient was to receive was on the wrong refrigerator. The PREVNAR was in the refrigerator where the 23v polysaccharide vaccine should have been. The person administering the drug did not look to see it was the wrong one. No adverse reactions reported. No further information available. Additional information has been requested.
Initial unsolicited report received from a non-health care professional on 12-Oct-2017. This case is considered as invalid as patient identifier was not reported. This case involves vaccination with dose of FLUZONE HD (Batch number, expiry date, dose, dose in series, expiry date, route and site not reported) on an unknown date. The patient's medical history was not reported. Concomitant medications was not reported. On an unknown date, following the vaccination, the patient had cold chills. Lab data and corrective treatment were not reported. Outcome of the events were not reported. List of documents held by sender: none
Post HPV (1st dose), Menactra (2nd dose), HEP A (2nd dose) Petite mal seizure occurred-clenched teeth no fists x 30 seconds-post sobbing, no vomiting or defraction following impact.
severe tinnitus (still have though not acute) blood clot, traveled to lungs causing pulmonary embolism
Bone crushing pain. Itchy eyes. Weird dreams. Arm where vaccine was administrated hot swollen. Pain at injection site.
1st dose on 22Sep2022, 2nd on 30Jan2023; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a female patient who received HAB (Twinrix) for prophylaxis.   Previously administered products included Twinrix (received 1st dose on 22th September 2022).   On 30-JAN-2023, the patient received the 2nd dose of Twinrix. On 30-JAN-2023, an unknown time after receiving Twinrix, the patient experienced drug dose administration interval too long (Verbatim: 1st dose on 22Sep2022, 2nd on 30Jan2023). The outcome of the drug dose administration interval too long was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt date: 27-Mar-2023 Pharmacist stated that a patient did not get her 2nd dose of Twinrix on schedule and would like to know how to proceed with dosing. The reporter did not consent to follow-up. The patient received 2nd dose of Twinrix later than the recommended schedule, which led to lengthening of vaccination schedule.
My lymph nodes under my arm are swollen, headache, asthma, flu symptoms, entire body aches, coughing, and tiredness.
5-16-18 4:10pm After receiving 2 injections was standing at Front Desk- verbalize feeling faint - Assisted to Floor by Nurse - no loss of consciousness. In about 5 min assisted to exam table - stating she feeling better BP 106/76 Drank 8oz regular coke, ate cookies. 4:30pm stating feeling ok, no lightheadedness. Ambulated to car with nurse by side- mother present.
10/06/00-10/09/00: She seemed to be getting stuffy. Had an existing reflux problem but spitting up was never an issue. After the vaccine she started spitting up after most feedings. Crying a lot; 20 minutes at a time, hard to console. She seemed a little paler than usual. October 10: called pediatrician saying she was very stuffy, watery eyes, waking up from sleep crying, very fussy. She had a fever of 101.1 asked if this could be from the vaccine and they said no. I was told she probably had a cold and that a fever of 101 was safe for a 2 month old. They told me to increase her Pepsid dose ot help with the spitting up, put cold compresses on her to reduce her fever, and to aspirate her nose to help her breathe. Over next week she seemed low energy, slept a lot more, cried a lot, seemed 'zoned out," not her normally alert, responsive self, continue to be paler than normal. The following week she seemed to be little better: less crying, still seemed pale and low energy, sleeping and zoning out a lot. Still a little pale. October 30: 3month birthday. I consulted my new mother journal and realized she had been babbling prior to the vaccine and this had stopped immediately after. Did research and found that kids may quit babbling because they are deaf. We home tested with extremely loud noises and found she had lost her hearing. We took her to the pediatrician who confirmed she was having problems but told us not to worry because "kids sometimes go through a phase like this." He scheduled us to have a hearing test done on 11/27/2000. 11/17/2000. Took the pt to see a homepath. Doctor diagnosed that the pt had suffered encephalitis from the vaccine. Unsure which due to the large number given at once. He did a craniosacral treatment on her and gave us a remedy: opium. She responded quickly to the remedy. We noticed a difference in her within 48 hours. Three days later we tested her and it was obvious her hearing was returning. Within the week she was 80% back to the child prior to the vaccine. Hearing tests with audiologist on 11/27/00 confirmed that her hearing was back 100%. Follow-up with pediatrician: reported results and he did not acknowledge the diagnosis. He told us they don't give out adverse reaction info because they feel "the vaccines are so safe now there's no need to." After the face they sent us the information with a letter apologizing for not doing so at the appropriate time. We switched from out pediatrician to our family physician. He would not record or acknowledge that she had a vaccine reaction so we switched to our current family doctor. She had been on metroclopromide three weeks prior to the vaccine.
All three: chills, ache, sore arm, headache Booster: same as above but under armpit soreness in lymph nodes
Pain on her right shoulder blade; Middle back pain; Hip pain; Lower stomach pain; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN LOWER (Lower stomach pain), BACK PAIN (Middle back pain), ARTHRALGIA (Hip pain) and ARTHRALGIA (Pain on her right shoulder blade) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027B21A and 014M20A) for COVID-19 vaccination.     No medical history were provided by the reporter.  Concomitant products included LOSARTAN and SIMVASTATIN for an unknown indication.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced ABDOMINAL PAIN LOWER (Lower stomach pain) and ARTHRALGIA (Hip pain). On 04-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced BACK PAIN (Middle back pain). On 06-Apr-2021, the patient experienced ARTHRALGIA (Pain on her right shoulder blade). At the time of the report, ABDOMINAL PAIN LOWER (Lower stomach pain), BACK PAIN (Middle back pain), ARTHRALGIA (Hip pain) and ARTHRALGIA (Pain on her right shoulder blade) outcome was unknown. Not Provided          Treatment drugs not provided.
This spontaneous report was received from a registered nurse, concerning a 42 year old patient of an unknown gender. The patient's medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On 14-NOV-2017, the patient was vaccinated with PROQUAD from lot # M036294 with expiration date on 13-FEB-2018 (strength, dose, and anatomical location were not reported), administered subcutaneously for prophylaxis; which was considered as an inappropriate age at vaccine administration. No side effects were reported. No product quality complaint (PQC) was involved.
Arm pain, elevated temperature 99.5, head ache, light sensitivity. I couldn?t work or sleep and had to stay in a dark room the entire day after
test positive after 1st dose; little, slight muscle aches; pain at the injection site; This is a spontaneous report from a Non contactable Consumer. This Consumer reported for a male patient (husband) that:  A 72-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), 1st dose Solution for injection, Lot number EL9264-A) via an unspecified route of administration, on 29Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient experienced SARS-CoV-1 test positive, muscle pain, vaccination site pain. The patient went into quarantine. Quarantine ended on 19Feb2021. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 07Feb2021 and on 22Feb2021 sars-cov-2 test: negative. on an unspecified date with outcome of the events was unknown. The reporter stated that their quarantine is way over, and they have no symptoms or anything like that, and they were told to wait to get the second dose after a couple weeks, and it has been more than couple weeks that have gone by. They were told that they may have antibodies, and that they should wait 3 months until after they contracted COVID to get the second dose, which they would like to know if this is correct.  No follow-up attempts are possible. No further information is expected.
RED RASH TO BOTHARMS FLEXOR ASPECT AND ABDOMEN TREATED WITH HYDROCORTISONE AND BENDRYL
She got her vaccine, she had no issues.  Then at 3:30 AM Tuesday morning she was sweating, stiff as a board and lives alone.  She took a Tylenol, and drank a bottle of water and started walking around.  She was achy and stiff, scared.  Then she started thinking that she had the shot, and decided to call the office today.  She gave her our website to go on, and copied the phone # and called us.  She told her what symptoms she was having and was told to stay hydrated.  She is feeling better today, got up and did her chair exercises, etc.  She has the stinging feeling under arm still today.
R arm swelling, red, pain for less than or equal to 48 hrs. Tx: ice no md.
DONOR WOKE UP MORNING OF 7/16/15 WITH TINGLING IN HANDS AND FEET. TWO DAYS AFTER INTIAL SYMPTOMS DONOR HAD SWOLLEN GLANDS. ON 7/20/15 DONOR HAD FEVER, CHILLS, STOMACH ACHE, TINGLING, HEADACHE, AND A SWOLLEN RED ARM. ALL SYMPTOMS FROM 7/20/15 CONTINUE TODAY.
Often severe pain in neck/arm/leg muscles and joints Recurring mouth ulcers  Unusual neurological symptoms "brain fog" off and on since vaccinations Anxiety/depression symptoms starting in December of 2021 and lasting throughout 2022
This case was reported by a physician and described the occurrence of elevated liver function test in a 15-year-old female subject who was vaccinated with HAVRIX (GlaxoSmithKline). Concurrent vaccination included GARDASIL given on 27 May 2008. There were no concurrent medications. On 27 May 2008 at 16:45 the subject received 2nd dose of HAVRIX in the left arm. On 30 May 2008, 3 days after vaccination with HAVRIX, the subject developed a fever of 102 degrees. On 02 June 2008, the subject's fever had not resolved and the reporting physician sent the subject for blood work. Her CBC was 6300, epstein barr test was negative, all chemistries were normal with the exception of the following elevated liver function tests: GGT: 104, AST: 428, ALT: 352, LD: 786, bilirubin was 0.6 and her alkaline phosphatase was 92. This case was assessed as medically serious by GSK. At the time of reporting the subject fever was resolved (June 2008) and the outcome of the other events was unspecified. The physician considered the events were possibly related to vaccination with HAVRIX.
This is more like a side effect no adverse effect as of today. Since my first dosage during my last two ovulations months I have experience more intense breast pain and I never feel like that. After ovulation is over pain goes away as normal.
patient stated the injection site had unusual hardness, redness, itching, and a greater than 2 inch circumference at the injection site. the reaction started one day after the injection and lasted for approximately 7 days.  after 7 days the area was still hard but no longer red or sore
Flu like symptoms; This case was reported by a consumer and described the occurrence of influenza-like symptoms in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was unknown.   It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The age group was captured as adult as per vaccine indication. The patient experienced flu like symptoms after the 2nd dose of Shingrix. The patient asked how long did flu like symptoms last?
After 2nd dose, I started bruising badly. I went in for a blood test and my platelets were at 4000. It looked like I had chicken pox and I had uncontrollable itching. I was hospitalized for platelets and after 5 units of IV therapy, I had platelet count of 1000 because it didn't work. I started on steroids for platelets. Since then, my platelets have normalized. I was bruised from head to toe. I am actively seeing hematology.
During the first 24 hrs, symptoms included: redness, swelling and ache at site of injection; tiredness. On Jan 27th (7 days following vaccination) a large (2.5" X 4") red area formed around the injection site on my arm and it began to ache and itch. I also had diarrhea which began in the middle of the night (2 am on Jan 28), with a total of 3 episodes over 3 hours. That day I was very tired, experienced intestinal upset  (w/ very small episodes of diarrhea) and my arm began to really ache and the swollen area became rather firm and hot. The intestinal episode is over but the hot red welt continues as of this report. Diarrhea is not a common condition for me.
On 8-9-2010 client was given H1N1 0.1ml. intradermally instead of TB-PPD in the left inner forearm. 08-11-2010 - at injection site, very slight pink color of 1cm-2cm. No c/o discomfort. 8-13-2010 c/o systemic itching. No redness at site.
Became aware of periodic high-pitched whine (bilateral, but louder in right ear) about 3 weeks after receiving first dose; quickly developed into constant tinnitus. Received second dose on 4/15/21. Tinnitus has not gotten worse, but I now also have a feeling of fullness in my right ear. My hearing does not seem affected at this point. No previous history of chronic tinnitus.
pt exp extreme tightness in chest, difficulty breathing, beginning the evening of shot & lasting approx 36 hrs; pt did not seek physician's care but treated self w/rest & nl meds;
7p-itching began back of neck-sore throat. 10p-rash quickly spread from back of neck face "puffy". Rash became confluent. 4a at ER: Tx-Atarax, Pepcid and "Astoraid." Puffy face resolved after 2 days. Rash resolved after 5 days. Hives on face comes and goes.
hearing loss; my left ear felt clogged; I developed the feeling of being underwater; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 17Sep2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 50 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "ME" (unspecified if ongoing); "CFS" (unspecified if ongoing); "Known allergies Yes; IV Contrast for CT scans" (unspecified if ongoing). Concomitant medication(s) included: SHINGRIX, on 06Sep2022 as dose 2, single; FLU [INFLUENZA VACCINE], on 06Sep2022 as dose number unknown, single. Vaccination history included: Covid-19 vaccine (DOSE: 4, Unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (DOSE: 3, Unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (DOSE: 2, unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (DOSE: 1, Unknown manufacturer), for COVID-19 immunization; Shringrx (DOSE: 1). The following information was reported: FEELING ABNORMAL (disability) with onset 17Sep2022, outcome "not recovered", described as "I developed the feeling of being underwater"; DEAFNESS (disability, medically significant) with onset 17Sep2022, outcome "not recovered", described as "hearing loss"; EAR DISCOMFORT (disability) with onset 17Sep2022, outcome "not recovered", described as "my left ear felt clogged". The events "hearing loss", "my left ear felt clogged" and "i developed the feeling of being underwater" required physician office visit. Therapeutic measures were taken as a result of deafness, ear discomfort, feeling abnormal. Clinical course: 15 minutes after the vaccination left ear felt clogged. Patient developed the feeling of being underwater, and noticed hearing loss. Treatment inlcuded prednisone and ear cleaning. Patient had no covid prior vaccination. Patient had no covid tested post vaccination.   The information on the batch/lot number for [BNT162B2] has been requested and will be submitted if and when received.
My symptoms started on 3/30/2023 which started in the morning. I was coughing, congested, fatigue and sore all over on my muscles. I had sore throat and did not have a fever. This was 3 days. On 3/31/2023 I called the telehealth and the nurse practitioner have me PAXLOVID. The symptoms improved by 4/3/23 and on 4/4/23 I felt normal. On the 4/6/23. I tested negative.
Initially noted some pain in my armpit on the same arm as the injection site (right arm). Within several hours the pain location broadened. Fluid accumulated under my armpit, towards my right nipple. The swelling/fluid buildup was very visibly  noticeable, giving the appearance of a female breast. Pain controlled with Tylenol. The swelling went down over 1-2 days.
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Endometrial cancer and Blood pressure abnormal (Patient's blood pressure was going up and down and still  was not stable.). Concomitant products included LENVATINIB MESILATE (LENVIMA) from 11-Feb-2021 to 12-Feb-2021 for Endometrial cancer.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       The patient mentioned he would get the second dose of Moderna vaccine on an unknown date in Mar-2021.
Approximately 12 hours post vaccination employee reported hives consisting of raised, itchy whelps from their waist to their ears.  Hives reported as moderate to severe - kept employee up all night due to severe itching. Employee reports no increased heart rate, no difficulty breathing or shortness of breath, no fever, no direct pain or redness aside from the hives a the injection site, no nausea no vomiting. Employee took a dose of Benadryl when hives started, this seemed to resolve about 50% of them by 8am the following morning, a second dose of Benadryl was taken at 8am 12/31/2020, and by 12pm 12/31/2020 the hives were gone.
A 13-year-old was provided the 5 to 11-year-old Pfizer vaccination. Patient needed the 12 and up Pfizer vaccine based on age screening. Immunizations clinic had the vaccines separated and labeled properly. The failure occurred during screening when the age of the patient was not taken into account properly, and personnel did not double verify the vaccines prior to being administered.
Bright Red Mark; Hardness; Warm (red mark); This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Bright Red Mark), VACCINATION SITE PAIN (Hardness) and VACCINATION SITE WARMTH (Warm (red mark)) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for an unknown indication.     The patient's past medical history details were not included. Concomittant product usage were also not provided.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced ERYTHEMA (Bright Red Mark), VACCINATION SITE PAIN (Hardness) and VACCINATION SITE WARMTH (Warm (red mark)). At the time of the report, ERYTHEMA (Bright Red Mark), VACCINATION SITE PAIN (Hardness) and VACCINATION SITE WARMTH (Warm (red mark)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Seizure occurred about 5 minutes after receiving vaccination. Seizure lasted about 10 seconds
Patient was administered 0.3mL instead of 0.5mL. of Moderna Bivalent. Flu vaccine was given correctly.